Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

The MBNL/CELF Splicing Factors Regulate Cytosolic Sulfotransferase 4A1 protein expression During Cell Differentiation.

Idris M, Butcher NJ, Minchin RF.

Drug Metab Dispos. 2019 Jan 3. pii: dmd.118.085290. doi: 10.1124/dmd.118.085290. [Epub ahead of print]

PMID:
30606728
2.

Allosteric regulation of arylamine N-acetyltransferase 1 by adenosine triphosphate.

Minchin RF, Rosengren KJ, Burow R, Butcher NJ.

Biochem Pharmacol. 2018 Dec;158:153-160. doi: 10.1016/j.bcp.2018.10.013. Epub 2018 Oct 17.

PMID:
30342020
3.
4.

Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.

Wang L, Minchin RF, Butcher NJ.

PLoS One. 2018 Mar 8;13(3):e0193560. doi: 10.1371/journal.pone.0193560. eCollection 2018.

5.

Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease.

Butcher NJ, Horne MK, Mellick GD, Fowler CJ, Masters CL; AIBL research group, Minchin RF.

Pharmacogenomics J. 2018 Apr;18(2):209-214. doi: 10.1038/tpj.2017.4. Epub 2017 Apr 4.

PMID:
28374858
6.

Cryptic epitopes and functional diversity in extracellular proteins.

Mortimer GM, Minchin RF.

Int J Biochem Cell Biol. 2016 Dec;81(Pt A):112-120. doi: 10.1016/j.biocel.2016.10.020. Epub 2016 Oct 27. Review.

PMID:
27989962
7.

Role for human arylamine N-acetyltransferase 1 in the methionine salvage pathway.

Witham KL, Minchin RF, Butcher NJ.

Biochem Pharmacol. 2017 Feb 1;125:93-100. doi: 10.1016/j.bcp.2016.11.015. Epub 2016 Nov 16.

PMID:
27865712
8.

Release of bioactive peptides from polyurethane films in vitro and in vivo: Effect of polymer composition.

Zhang J, Woodruff TM, Clark RJ, Martin DJ, Minchin RF.

Acta Biomater. 2016 Sep 1;41:264-72. doi: 10.1016/j.actbio.2016.05.034. Epub 2016 May 28.

PMID:
27245428
9.

Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages.

Shaw CA, Mortimer GM, Deng ZJ, Carter ES, Connell SP, Miller MR, Duffin R, Newby DE, Hadoke PW, Minchin RF.

Nanotoxicology. 2016 Sep;10(7):981-91. doi: 10.3109/17435390.2016.1155672. Epub 2016 Mar 30.

PMID:
27027807
10.

Drug delivery: Unravelling the stealth effect.

Butcher NJ, Mortimer GM, Minchin RF.

Nat Nanotechnol. 2016 Apr;11(4):310-1. doi: 10.1038/nnano.2016.6. Epub 2016 Feb 15. No abstract available.

PMID:
26878145
11.

Stable non-covalent labeling of layered silicate nanoparticles for biological imaging.

Mortimer GM, Jack KS, Musumeci AW, Martin DJ, Minchin RF.

Mater Sci Eng C Mater Biol Appl. 2016 Apr 1;61:674-80. doi: 10.1016/j.msec.2015.12.047. Epub 2015 Dec 22.

PMID:
26838896
12.

Fluoromica nanoparticle cytotoxicity in macrophages decreases with size and extent of uptake.

Tee N, Zhu Y, Mortimer GM, Martin DJ, Minchin RF.

Int J Nanomedicine. 2015 Mar 26;10:2363-75. doi: 10.2147/IJN.S80655. eCollection 2015.

13.

The role of lysine(100) in the binding of acetylcoenzyme A to human arylamine N-acetyltransferase 1: implications for other acetyltransferases.

Minchin RF, Butcher NJ.

Biochem Pharmacol. 2015 Apr 1;94(3):195-202. doi: 10.1016/j.bcp.2015.01.015. Epub 2015 Feb 4.

PMID:
25660616
14.

Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.

Tiang JM, Butcher NJ, Minchin RF.

Cancer Med. 2015 Apr;4(4):565-74. doi: 10.1002/cam4.415. Epub 2015 Jan 28.

15.

A bag of cells approach for antinuclear antibodies HEp-2 image classification.

Wiliem A, Hobson P, Minchin RF, Lovell BC.

Cytometry A. 2015 Jun;87(6):549-57. doi: 10.1002/cyto.a.22597. Epub 2014 Dec 9.

16.

Expression of the orphan cytosolic sulfotransferase SULT4A1 and its major splice variant in human tissues and cells: dimerization, degradation and polyubiquitination.

Sidharthan NP, Butcher NJ, Mitchell DJ, Minchin RF.

PLoS One. 2014 Jul 2;9(7):e101520. doi: 10.1371/journal.pone.0101520. eCollection 2014.

17.

Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials.

Mortimer GM, Butcher NJ, Musumeci AW, Deng ZJ, Martin DJ, Minchin RF.

ACS Nano. 2014 Apr 22;8(4):3357-66. doi: 10.1021/nn405830g. Epub 2014 Mar 27.

PMID:
24617595
18.

Interaction of human arylamine N-acetyltransferase 1 with different nanomaterials.

Deng ZJ, Butcher NJ, Mortimer GM, Jia Z, Monteiro MJ, Martin DJ, Minchin RF.

Drug Metab Dispos. 2014 Mar;42(3):377-83. doi: 10.1124/dmd.113.055988. Epub 2013 Dec 17.

19.

5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion.

Witham KL, Butcher NJ, Sugamori KS, Brenneman D, Grant DM, Minchin RF.

PLoS One. 2013 Oct 25;8(10):e77923. doi: 10.1371/journal.pone.0077923. eCollection 2013.

20.

Exocytosis of nanoparticles from cells: role in cellular retention and toxicity.

Sakhtianchi R, Minchin RF, Lee KB, Alkilany AM, Serpooshan V, Mahmoudi M.

Adv Colloid Interface Sci. 2013 Dec;201-202:18-29. doi: 10.1016/j.cis.2013.10.013. Epub 2013 Oct 23. Review.

PMID:
24200091
21.

Cytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-D-aspartate receptor coupling.

Sidharthan NP, Minchin RF, Butcher NJ.

J Biol Chem. 2013 Nov 29;288(48):34364-74. doi: 10.1074/jbc.M113.493239. Epub 2013 Oct 17.

22.

Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen.

Deng ZJ, Liang M, Toth I, Monteiro MJ, Minchin RF.

ACS Nano. 2012 Oct 23;6(10):8962-9. doi: 10.1021/nn3029953. Epub 2012 Sep 25.

PMID:
22998416
23.

Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.

Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, Minchin RF, Guminski A.

EMBO Mol Med. 2012 Aug;4(8):675-84. doi: 10.1002/emmm.201101131. Epub 2012 Jun 25. Review.

24.

Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses.

Deng ZJ, Liang M, Toth I, Monteiro M, Minchin RF.

Nanotoxicology. 2013 May;7(3):314-22. doi: 10.3109/17435390.2012.655342. Epub 2012 Mar 6.

PMID:
22394123
25.

Arylamine N-acetyltransferase 1: a novel drug target in cancer development.

Butcher NJ, Minchin RF.

Pharmacol Rev. 2012 Jan;64(1):147-65. doi: 10.1124/pr.110.004275. Epub 2011 Nov 16. Review.

26.

RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition.

Tiang JM, Butcher NJ, Cullinane C, Humbert PO, Minchin RF.

PLoS One. 2011 Feb 9;6(2):e17031. doi: 10.1371/journal.pone.0017031.

27.

Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.

Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF.

Nat Nanotechnol. 2011 Jan;6(1):39-44. doi: 10.1038/nnano.2010.250. Epub 2010 Dec 19.

PMID:
21170037
28.

Phosphorylation/dephosphorylation of human SULT4A1: role of Erk1 and PP2A.

Mitchell DJ, Butcher NJ, Minchin RF.

Biochim Biophys Acta. 2011 Jan;1813(1):231-7. doi: 10.1016/j.bbamcr.2010.09.011. Epub 2010 Oct 12.

29.

Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells.

Paterson S, Sin KL, Tiang JM, Minchin RF, Butcher NJ.

Drug Metab Dispos. 2011 Jan;39(1):77-82. doi: 10.1124/dmd.110.036202. Epub 2010 Sep 24.

30.

Regulation of mouse brain-selective sulfotransferase sult4a1 by cAMP response element-binding protein and activating transcription factor-2.

Butcher NJ, Mitchell DJ, Burow R, Minchin RF.

Mol Pharmacol. 2010 Sep;78(3):503-10. doi: 10.1124/mol.110.063404. Epub 2010 Jun 22.

31.

Endosomal disruptors in non-viral gene delivery.

Minchin RF, Yang S.

Expert Opin Drug Deliv. 2010 Mar;7(3):331-9. doi: 10.1517/17425240903512931. Review.

PMID:
20201737
32.

Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1.

Butcher NJ, Minchin RF.

Carcinogenesis. 2010 May;31(5):820-6. doi: 10.1093/carcin/bgq042. Epub 2010 Feb 22.

PMID:
20176657
33.

Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells.

Tiang JM, Butcher NJ, Minchin RF.

Biochem Biophys Res Commun. 2010 Feb 26;393(1):95-100. doi: 10.1016/j.bbrc.2010.01.087. Epub 2010 Jan 25.

PMID:
20100460
34.

Nanoparticles for molecular imaging--an overview.

Minchin RF, Martin DJ.

Endocrinology. 2010 Feb;151(2):474-81. doi: 10.1210/en.2009-1012. Epub 2009 Dec 16. Review.

PMID:
20016027
35.

Cellular uptake of densely packed polymer coatings on gold nanoparticles.

Liang M, Lin IC, Whittaker MR, Minchin RF, Monteiro MJ, Toth I.

ACS Nano. 2010 Jan 26;4(1):403-13. doi: 10.1021/nn9011237.

PMID:
19947583
36.

Differential plasma protein binding to metal oxide nanoparticles.

Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF.

Nanotechnology. 2009 Nov 11;20(45):455101. doi: 10.1088/0957-4484/20/45/455101. Epub 2009 Oct 13.

PMID:
19822937
37.

Cytosolic Aryl sulfotransferase 4A1 interacts with the peptidyl prolyl cis-trans isomerase Pin1.

Mitchell DJ, Minchin RF.

Mol Pharmacol. 2009 Aug;76(2):388-95. doi: 10.1124/mol.109.055442. Epub 2009 May 13.

38.

Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine.

Yang S, Coles DJ, Esposito A, Mitchell DJ, Toth I, Minchin RF.

J Control Release. 2009 Apr 17;135(2):159-65. doi: 10.1016/j.jconrel.2008.12.015. Epub 2009 Jan 9.

PMID:
19171168
39.

Lack of exonic sulfotransferase 4A1 mutations in controls and schizophrenia cases.

Lewis AG, Minchin RF.

Psychiatr Genet. 2009 Feb;19(1):53-5. doi: 10.1097/YPG.0b013e3283118776.

PMID:
19125109
40.

Regulation of arylamine N-acetyltransferases.

Butcher NJ, Tiang J, Minchin RF.

Curr Drug Metab. 2008 Jul;9(6):498-504. Review.

PMID:
18680469
41.

E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2.

Mitchell DJ, Minchin RF.

Cancer Gene Ther. 2008 Nov;15(11):758-64. doi: 10.1038/cgt.2008.47. Epub 2008 Jul 4.

PMID:
18600257
42.

The characterization of a novel dendritic system for gene delivery by isothermal titration calorimetry.

Coles DJ, Yang S, Minchin RF, Toth I.

Biopolymers. 2008;90(5):651-4. doi: 10.1002/bip.21019.

PMID:
18481807
43.

Changes in consensus arylamine N-acetyltransferase gene nomenclature.

Hein DW, Boukouvala S, Grant DM, Minchin RF, Sim E.

Pharmacogenet Genomics. 2008 Apr;18(4):367-8. doi: 10.1097/FPC.0b013e3282f60db0.

44.

Sulfotransferase 4A1.

Minchin RF, Lewis A, Mitchell D, Kadlubar FF, McManus ME.

Int J Biochem Cell Biol. 2008;40(12):2686-91. doi: 10.1016/j.biocel.2007.11.010. Epub 2007 Dec 3. Review.

PMID:
18248844
45.

Modified influenza virosomes: recent advances and potential in gene delivery.

Khoshnejad M, Young PR, Toth I, Minchin RF.

Curr Med Chem. 2007;14(29):3152-6. Review.

PMID:
18220748
46.

Polyamine-dependent regulation of spermidine-spermine N1-acetyltransferase mRNA translation.

Butcher NJ, Broadhurst GM, Minchin RF.

J Biol Chem. 2007 Sep 28;282(39):28530-9. Epub 2007 Aug 9.

47.

Arylamine N-acetyltransferase I.

Minchin RF, Hanna PE, Dupret JM, Wagner CR, Rodrigues-Lima F, Butcher NJ.

Int J Biochem Cell Biol. 2007;39(11):1999-2005. Epub 2007 Jan 20.

PMID:
17392017
48.

Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells.

Butcher NJ, Tetlow NL, Cheung C, Broadhurst GM, Minchin RF.

Cancer Res. 2007 Jan 1;67(1):85-92.

49.

Concentration-dependent effects of N1, N11-diethylnorspermine on melanoma cell proliferation.

Minchin RF, Knight S, Arulpragasam A, Fogel-Petrovic M.

Int J Cancer. 2006 Jan 15;118(2):509-12.

50.

HIV LTR-dependent expression of Bax selectively induces apoptosis in Tat-positive cells.

McCoubrie JE, Kendrick TS, Minchin RF.

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1459-64.

PMID:
15555592

Supplemental Content

Loading ...
Support Center